Phase III trial of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (MAYO) vs. weekly oxaliplatin (OXA) plus high dose 24h 5-FU infusion/FA in patients with advanced colorectal cancer (CRC)
Authors:
- A. GrotheyAGA. Grothey
- T. BuecheleTBT. Buechele
- H. KroeningHKH. Kroening
- K. RidwelskiKRK. Ridwelski
- P. ReichardtPRP. Reichardt
- A. KretzschmarAKA. Kretzschmar
- M. ClemensMCM. Clemens
- H.J. SchmollHSH.J. Schmoll
- 1 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer
- Vol. 37, S257